MedTrace Logo

Vitamin D Supplementation in Healthy Adolescents

NCT01126671 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 56

Last updated 2018-06-04

Study results available
· View outcomes & findings →

Summary

This double blind, randomized controlled trial compares two supplemental doses of vitamin D in health adolescents.

Conditions

  • Vitamin D Supplementation

Interventions

DRUG

Supplemental Vitamin D

Subjects were randomized to either take 200 IU of vitamin D or 1000 IU of vitamin D daily for 11 weeks and labs were compared before and after.

Sponsors & Collaborators

Principal Investigators

  • Melissa Putman, MD · Childrens Hospital, Boston

  • Sarah Pitts, MD · Childrens Hospital, Boston

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
11 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-11-30
Primary Completion
2011-06-30
Completion
2011-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01126671 on ClinicalTrials.gov